ProteinSimple Sally Sue
17 December 2015 | By ProteinSimple
Simple Western™ system that can generate up to 96 data points in a single experiment, handling your low, medium or high throughput Simple Western needs…
List view / Grid view
A drug target is anything within a living organism to which a drug is directed and/or binds, resulting in a change in its behaviour or function.
17 December 2015 | By ProteinSimple
Simple Western™ system that can generate up to 96 data points in a single experiment, handling your low, medium or high throughput Simple Western needs…
16 December 2015 | By ProteinSimple
FluorChem M sets a new standard for quantitative Western blot detection...
15 December 2015 | By ProteinSimple
iCE has the resolution of traditional gel IEF but incorporates the advantages of quantitation and automation...
14 December 2015 | By ProteinSimple
The FluorChem E Digital Darkroom redefines high-performance Western blot and gel imaging...
13 December 2015 | By ProteinSimple
AlphaImager Mini is a compact and economical digital imaging system, ideal for routine imaging of fluorescent and colorimetric DNA and protein gels...
11 December 2015 | By Victoria White
The companies have joined WCPR to develop new technologies for biologics production and to identify new targets for disease research in the ground-breaking area of the Secretome...
6 December 2015 | By ProteinSimple
This video provides an overview of the features from the Simple Western product range by ProteinSimple, including Wes, Sally Sue, Peggy Sue or NanoPro 1000...
5 December 2015 | By ProteinSimple
Ella runs hands-free, multiplex-free, ELISA-free Simple Plex assays. She’ll give you results for multiple samples in 60 minutes flat...
4 December 2015 | By ProteinSimple
Address the US FDA requirement to characterize and quantify protein aggregates and other particle contaminants sized 1-70 microns in biotherapeutics...
3 December 2015 | By ProteinSimple
Simple Western™ system that can separate, analyse and quantify proteins based on either size or charge…
The pharmaceutical industry is searching for novel drug targets that could produce the next generation of ‘first-in-class’ therapeutic agents. The challenge for academia is to identify and translate such targets and to provide starting points and confidence in the underlying science. The aim should be to generate evidence that modulation…
2 December 2015 | By ProteinSimple
Simple Western™ system for the characterization of post-translational protein modification by the detection of charge isoforms...
30 November 2015 | By Victoria White
By removing these interactions, the researchers partially restored the protein’s normal function. The findings suggest that therapies could one day treat the root cause of cystic fibrosis, not just the symptoms...
22 November 2015 | By Illumina
In this webinar, we focus on the use of microarray technology in drug development...
17 November 2015 | By Victoria White
Antibodies against TIGIT could improve the function of the DNAM-1 protein, thereby improving the ability of natural killer cells to destroy tumour cells...